Efficacy and safety of lixisenatide as add-on therapy to basal insulin in older adults with type 2 diabetes in the GetGoal-O Study. [electronic resource]
Producer: 20200421Description: 971-981 p. digitalISSN:- 1753-0407
- Age Factors
- Aged
- Aged, 80 and over
- Biomarkers -- blood
- Blood Glucose -- drug effects
- Diabetes Mellitus, Type 2 -- blood
- Double-Blind Method
- Drug Therapy, Combination
- Female
- Glucagon-Like Peptide-1 Receptor -- metabolism
- Glycated Hemoglobin -- metabolism
- Humans
- Hypoglycemic Agents -- administration & dosage
- Incretins -- administration & dosage
- Insulin Glargine -- administration & dosage
- Male
- Peptides -- administration & dosage
- Time Factors
- Treatment Outcome
- Glucagon-Like Peptide-1 Receptor Agonists
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.